LiliPeptide
Finnrick has tested 221 samples from LiliPeptide across 8 products.
Finnrick Vendor Profile
to
LiliPeptide
Tracking 8 products
221 total samples tested
Last test 13 Apr 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| BPC-157 | 17 | 25 Sep 2025 | 21 Mar 2026 | |||||
| GHK-Cu | 20 | 25 Sep 2025 | 21 Mar 2026 | |||||
| Ipamorelin | 7 | 25 Sep 2025 | 9 Feb 2026 | |||||
| TB-500 | 10 | 9 Sep 2025 | 18 Mar 2026 | |||||
| PT-141 | 8 | 25 Sep 2025 | 10 Feb 2026 | |||||
| Retatrutide | 115 | 4 Aug 2025 | 25 Mar 2026 | |||||
| Tesamorelin | 15 | 17 Nov 2025 | 25 Mar 2026 | |||||
| Tirzepatide | 29 | 1 Sep 2025 | 13 Apr 2026 | |||||
The LiliPeptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.4
Based on 60 overall satisfaction reports
Ease of Purchase4.5(60)
Payment Methods4.3(60)
Delivery Speed4.2(60)
Packaging Quality4.4(60)
Customer Service4.5(56)
People who submitted test requests to Finnrick gave LiliPeptide an average satisfaction rating of 4.4 out of 5 across 60 reports associated with samples received and tested by Finnrick.
Most recent LiliPeptide tests
Samples are tested in commercial labs
221
tests
8
products
Scores
AVGMINMAX
First
4 Aug 2025
Last
13 Apr 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 13 Apr 2026 | Tirzepatide | View | 20mg | 21.5mg | +7.5% | 99.70% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 29 Mar 2026 | Tirzepatide | View | 30mg | 35.6mg | +18.7% | 99.80% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 25 Mar 2026 | Retatrutide | View | 10mg | 10.5mg | +5.0% | 99.70% | Jan 31, 2026 | No Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |
| 25 Mar 2026 | Retatrutide | View | 15mg | 16.1mg | +7.3% | 99.90% | January 4, 2026 | No Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 25 Mar 2026 | Tirzepatide | View | 30mg | 33.7mg | +12.3% | 99.90% | January 22, 2026 | No Label / Silver Crimp / Green Cap | Lab G | Public | |
| 25 Mar 2026 | Tesamorelin | View | 5mg | 6.3mg | +26.0% | 99.80% | 2/25/2026 | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 21 Mar 2026 | BPC-157 | View | 10mg | 10.5mg | +5.0% | 99.60% | January 31, 2026 | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
Corrections
- 5 Nov 2025: Retatrutide
- Lab G mistakenly entered 92 mg instead of 9.2 mg.